Ian T. Bothwell - 26 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
26 May 2021
Transactions value $
-$34,843
Form type
4
Date filed
28 May 2021, 21:43
Previous filing
25 May 2021
Next filing
03 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale -$7.72K -40K -0.03% $0.19 149M 26 May 2021 Direct
transaction OCEL Common Stock Sale -$9K -50K -0.03% $0.18 149M 27 May 2021 Direct
transaction OCEL Common Stock Sale -$6.96K -38.7K -0.03% $0.18 149M 27 May 2021 Direct
transaction OCEL Common Stock Sale -$2.07K -11.4K -0.01% $0.18 149M 27 May 2021 Direct
transaction OCEL Common Stock Sale -$9.1K -50K -0.03% $0.18 149M 28 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.